ESC 365 - The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial.

ESC Premium Access

The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial.

Session: Inflammation, diabetes and their influence on the heart

Topic: Drug therapy

Speaker: Doctor D. Shishikura (Takatsuki, JP)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Daisuke Shishikura

Osaka Medical and Pharmaceutical University, Takatsuki (Japan)

0 follower

6 more presentations in this session

Recombinant insulin-like growth factor-1 improves cardiac function and symptoms in the patients on the waiting list for heart transplantation with end-stage dilated cardiomyopathy

Speaker: Professor K. Komamura (Toyota, JP)

Direct ugmentation of cholesterol efflux capacity in AMI atients: a PKPD substudy of AEGIS-I

Speaker: Ms M. Yee (Boston, US)

Metformin epigenetically regulates tissue factor expression in diabetes

Speaker: Doctor M. Witkowski (Berlin, DE)

Effects of Tofogliflozin, an Sodium-glucose co-transporter 2 Inhibitor, on Cardiac Hypertrophy in Metabolic Model Rats

Speaker: Doctor T. Kimura (Fukuyama, JP)

Effect of TNF-a antagonists on wave reflections: a meta-analysis.

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Access the full session

Inflammation, diabetes and their influence on the heart

Speakers: Doctor D. Shishikura, Professor K. Komamura, Ms M. Yee, Doctor M. Witkowski, Doctor T. Kimura...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources